Novavax (NVAX) incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per share.Revenues in the quarter amounted to $85 million, which beat the Zacks Consensus Estimate of $57 million. However, the top line declined 55% on a year-over-year basis.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.More on NVAX’s EarningsNovavax recorded $38.2 million in produ ...